Clicky

Artrya Limited(AYA)

Description: Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) powered image-analysis software to enhance the detection and management of coronary artery disease. It offers Salix, a cloud-based software that uses its proprietary AI algorithms to interpret data from coronary computed tomography angiography scans and delivers findings in a single point of care solution. The company's Salix suite comprises Salix Coronary Anatomy and Salix Coronary Flow. It serves radiologists and cardiologists worldwide. The company was founded in 2018 and is based in Crawley, Australia.


Keywords: Medicine Clinical Medicine Artificial Intelligence Medical Technology Medical Imaging Radiology Cardiology Tomography Cloud Based Software Cardiovascular System Coronary Artery Disease Angiography Ct Scan Ai Algorithms X Ray Computed Tomography

Home Page: www.artrya.com

AYA Technical Analysis

1257 Hay Street
West Perth, WA 6005
Australia
Phone: 61 8 6478 7816


Officers

Name Title
Mr. John Windsor Barrington A.M., F.A.C.I.D., M.B.A. Co-founder, CEO, MD & Director
Mr. John Konstantopoulos B.E. Co-Founder, Exec. Director of Product & Director
Mr. Mark Wainwright Chief Financial Officer
Dr. Julien Flack Chief Technology Officer
Prof. Girish Dwivedi M.D. Chief Scientific Officer
Ms. Janice Marcon Chief People & Culture Officer
Dr. Jacob Agris M.D., Ph.D. Chief Medical Officer
Mr. Riaz Kingston Head of Bus. Devel.
Dr. Jacque J. Sokolov B.A., M.D. Non-Exec. Director, Chair & Pres of Artrya USA Inc
Mr. Ted Schwab Co-CEO of Artrya USA Inc

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.8489
Price-to-Sales TTM: 163.1758
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks